Moderne Biotechnologie ist allgegenwärtig

Maßnahmen gegen den Klimawandel oder den Treibhauseffekt sowie Technologien und Arzneien zur Behandlung von Krankheiten sind ohne Biotechnologie nicht denkbar. Erfahren Sie mehr über aktuelle Trends und Entwicklungen in der Biotechnologie in unserem Blog.

Repairing spinal cord injuries with nanotechnology

A Europe-wide project named “Piezo4Spine” sets the high goal of developing a novel therapy against spinal cord injuries (SCI). Based on the latest findings in materials science, regenerative medicine and nanotechnology, research is being conducted on a 3D-theramesh equipped with bioactive nanocarriers that delivers therapeutic agents to the site of the lesion through electrical stimulation. These bioactive ingredients activate the neuronal regeneration processes after an SCI has occurred. If successful, this technology could be useful in the future for pathologies such as Alzheimer’s or Parkinson’s disease, among others.

Continue reading
opium poppy plant

Enabling Alkaloid production in engineered poppy cells

Opiate alkaloids such as morphine and codeine are important pharmaceutical ingredients used to treat severe pain. Morphine is even classified as an essential medicine by the World Health Organization (WHO). Opiate-based medications are crucial to provide normal life for patients who need long-term pain management due to living with terminal cancer, sickle cell disease, COPD- related dyspnea, (etc.). Unfortunately, morphine is practically unavailable in low- and middle-income countries leaving patients in suffering.

Continue reading

Chemo-Enzymatic Route Scouting

You have a complex chemical process that is no longer competitive? Countries with low salary levels are beginning to gain market share for cost reasons? Let acib solve your problems by discovering new and cost-efficient routes for chemo-enzymatic synthesis of your target compound(s).

Continue reading

Bio-based production of glycosides

acib has a leading experience in industrial bioprocess design for enzymatic glycosylation reactions and is actively looking for new company collaborations interested in our glycosylation know-how.

Continue reading
No more posts to show
Skip to content